Stigma stops people from getting tested for HIV, and staying on their treatment. Unless it's addressed, the AIDS epidemic will persist.
Academic rigour, journalistic flair
Articles on ARVs
Displaying all articles
Up to 50% of the people who take the efavirenz antiretroviral react particularly badly to it and need to change drug regimens.
Current epidemiological and financial trends suggest there's a major risk of a substantial shortfall in the funds required to sustain life-saving antiretroviral programmes.
Young women in southern Africa are most at risk of becoming infected with HIV. If they take a pre-exposure prophylaxis like Truvada it could change their lives.
Job Board
Where experts find jobs
-
Academic Opportunities Digital Health
-
Advisor Diversity & Inclusion
-
Executive Director, Deakin Co.
-
Lecturer / Senior Lecturer In Clinical Dentistry
-
Lecturer In Behavioural Sleep Science
Top contributors
-
Director, Cochrane South Africa, South African Medical Research Council
-
Associate Professor and Director: Research at the Wits Reproductive Health and HIV Institute I, University of the Witwatersrand
-
Researcher and Programme Manager: Clinical Research Consortium for Wits Reproductive Health and HIV Institute (RHI), University of the Witwatersrand
-
Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town
-
Honorary Prof. of Clinical Pharmacology,, University of Cape Town
